Kathryn A. Phillips, PhD, is Professor of Health Economics and Health Services Research at the University of California, San Francisco (UCSF) and Founder/Director of the UCSF Center for Translational and Policy Research on Personalized Medicine (TRANSPERS). Kathryn holds degrees from UC-Berkeley, Harvard University (Kennedy School of Government), and UT-Austin, and previously spent eight years in the federal government. Kathryn focuses on the translation of new health care technologies into clinical care and health policy, particularly diagnostics and personalized medicine. Her expertise is in assessing the value of new technologies; the evidence needed to demonstrate value; what economic, regulatory, reimbursement, and market factors determine successful adoption; how private health plans make coverage and reimbursement decisions; and how care can become more personalized through consideration of consumer preferences and price transparency. Kathryn has advised or served as a board member for more than 35 biotech/pharma companies, venture capital firms, and consulting companies and is currently serving on three Scientific Advisory Boards (studies at Harvard Medical School and GenomeCanada).
Kathryn founded and directs TRANSPERS, a Center focused on the translation of personalized medicine into practice and policy (http://clinicalpharmacy.ucsf.edu/transpers/). TRANSPERS is a multi-million dollar effort, supported by the National Institutes of Health and several other organizations. Her integrative approach is illustrated by her leadership of the TRANSPERS Evidence and Reimbursement Advisory Council, which includes senior executives from the seven largest US health plans as well as thought leaders with industry, government, and Medicare perspectives. She was a founding member of the national advisory group that is reviewing genetic tests (EGAPP - Evaluation of Genomic Applications in Practice and Prevention), has served as an adviser to many organizations and regularly speaks to national and international groups. She has had continuous funding from the NIH as a Principal Investigator for over 20 years. Most recently, she was awarded a four-year NIH grant to examine benefit-risk tradeoffs for whole genome sequencing. She has published more than 100 peer-reviewed articles in journals such as JAMA, the New England Journal of Medicine, and Health Affairs, the pre-eminent journal in health policy. Kathryn serves on the editorial board for seven journals, including Health Affairs.